Central pontinemyelinosis, hyperparathyroidism, hypokalemia

Area of Science:

• Neurology
• Demyelinating Diseases

Background:

• Central pontine myelinolysis (CPM) is a rare non-inflammatory demyelinating disease primarily affecting the pons.
• Its exact etiopathogenesis remains unclear, with rapid correction of hyponatremia being a commonly cited factor.
• Other potential contributing factors include alcoholism, malnutrition, diuretic use, psychogenic polydipsia, post-liver transplant status, and hypokalemia.

Purpose of the Study:

• To describe a unique case of central pontine myelinosis (CPM).
• To investigate CPM occurrence in the absence of typical triggers like hyponatremia or rapid sodium correction.
• To explore the role of hyperparathyroidism, hypercalcemia, and severe hypokalemia in CPM development.

Main Methods:

• Case report detailing a patient with hyperparathyroidism and hypercalcemia.
• Clinical and laboratory investigations focusing on electrolyte balance and osmolality.
• Neurological examination and imaging to confirm central pontine myelinosis.

Main Results:

• The patient presented with central pontine myelinosis (CPM).
• CPM developed in the absence of hyponatremia/hyperosmolality or rapid correction of sodium levels.
• The condition was associated with hyperparathyroidism, hypercalcemia, and severe hypokalemia.

Conclusions:

• This case suggests that severe hypokalemia, in conjunction with hypercalcemia secondary to hyperparathyroidism, can lead to central pontine myelinosis (CPM).
• CPM may occur through alternative etiopathogenic pathways beyond the traditionally recognized rapid correction of hyponatremia.
• Further research is warranted to elucidate the complex mechanisms underlying CPM in diverse clinical scenarios.